FDA approves controversial Alzheimer’s drug

Global Business

Tens of millions of people worldwide suffer from Alzheimer’s, a form of dementia. There is no cure and treatments are limited.

But a new drug that has controversially just been approved by the U.S. Food & Drug Administration is providing hope it could delay the progression of the disease despite concerns over its efficacy.

CGTN’s Karina Huber reports.